- Home
- PHAT vs HBNC Comparison
PHAT vs HBNC Comparison
Compare PHAT & HBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PHAT | HBNC |
|---|---|---|
| Founded | 2018 | 1873 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 894.0M | 944.0M |
| IPO Year | 2019 | 1995 |
Fundamental Metrics
Financial Performance| Metric | PHAT | HBNC |
|---|---|---|
| Price | $9.62 | $18.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 4 |
| Target Price | $19.83 | ★ $21.00 |
| AVG Volume (30 Days) | ★ 1.2M | 218.7K |
| Earning Date | 04-30-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 3.57% |
| EPS Growth | ★ 42.72 | N/A |
| EPS | N/A | ★ 0.51 |
| Revenue | ★ $175,110,000.00 | N/A |
| Revenue This Year | $93.04 | N/A |
| Revenue Next Year | $58.91 | $5.52 |
| P/E Ratio | ★ N/A | $36.12 |
| Revenue Growth | ★ 216.93 | N/A |
| 52 Week Low | $4.25 | $14.38 |
| 52 Week High | $18.31 | $19.07 |
Technical Indicators
Market Signals| Indicator | PHAT | HBNC |
|---|---|---|
| Relative Strength Index (RSI) | 31.78 | 58.32 |
| Support Level | N/A | $17.07 |
| Resistance Level | $12.83 | $18.84 |
| Average True Range (ATR) | 0.72 | 0.38 |
| MACD | -0.26 | 0.01 |
| Stochastic Oscillator | 2.57 | 76.52 |
Price Performance
Historical ComparisonAbout PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About HBNC Horizon Bancorp Inc.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.